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Innate immunity relies on an effective recognition of the pathogenic microorganism as well 
as on endogenous danger signals. While bacteria in concert with their secreted virulence 
factors can cause a number of inflammatory reactions, danger signals released at the 
site of infection may in addition determine the amplitude of such responses and influence 
the outcome of the disease. Here, we report that protein SIC, Streptococcal Inhibitor of 
Complement, an abundant secreted protein from Streptococcus pyogenes, binds to extra-
cellular histones, a group of danger signals released during necrotizing tissue damage. This 
interaction leads to the formation of large aggregates in vitro. Extracellular histones and 
SIC are abundantly expressed and seen colocalized in biopsies from patients with necro-
tizing soft-tissue infections caused by S. pyogenes. In addition, binding of SIC to histones 
neutralized their antimicrobial activity. Likewise, the ability of histones to induce hemolysis 
was inhibited in the presence of SIC. However, when added to whole blood, SIC was not 
able to block the pro-inflammatory effect of histones. Instead SIC boosted the histone- 
triggered release of a broad range of cytokines and chemokines, including IL-6, TNF-α, IL-8, 
IL-1β, IL-1ra, G-CSF, and IFN-γ. These results demonstrate that the interaction between 
SIC and histones has multiple effects on the host response to S. pyogenes infection.
Keywords: extracellular histones, streptococcal inhibitor of complement, toll-like receptor, antimicrobial peptide, 
cytokines, Streptococcus pyogenes, innate immunity
inTrODUcTiOn
Streptococcus pyogenes (group A streptococcus, GAS) is an important human pathogen that may 
cause a number of conditions from harmless throat infections to invasive diseases such as sep-
ticemia, necrotizing soft-tissue infections (NSTI), and streptococcal toxic shock syndrome (1). 
The innate immune system is the first response to S. pyogenes infections. To counteract this and 
Abbreviations: GAS, group A streptococci; NSTI, necrotizing soft-tissue infection; AMPs, antimicrobial peptides; protein SIC, 
streptococcal inhibitor of complement; histones, calf thymus histones; SN, supernatant; CFUs, colony-forming units; HMGB1, 
high-mobility group box 1; HBP, heparin-binding protein; PBS-T, PBS containing 0.05% (v/v) Tween-20; PBS-G, PBS contain-
ing 5 mM glucose; ACIA, acquired computerized image analysis; TH, Todd–Hewitt; mga, multiple gene regulator of GAS.
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maintain colonization, S. pyogenes is equipped with an arsenal 
of virulence factors (for an excellent review, see Ref (2)). One of 
these is protein SIC (Streptococcal Inhibitor of Complement). 
SIC is a highly polymorphic 31 kDa negatively charged protein 
that is secreted by only a few M serotypes including M1, M12, 
M55, and M57. Originally, SIC was described to interfere with 
complement function (3, 4), but the last decade has demon-
strated that it exerts multifunctional activities and binds to 
several different ligands (5–9). Perhaps most importantly SIC 
blocks the cytolytic activity of several antimicrobial peptides 
(AMPs) such as LL-37, defensins, H-kininogens, H-kininogen-
derived peptides, and lysozyme (5–9). The binding of SIC 
to cationic AMPs is mediated by the negative charge of the 
streptococcal protein. It has been reported that upon binding to 
SIC, AMPs lose their cytolytic activity (6, 7). This is considered 
as an important mechanism for host colonization as it prevents 
bacterial degradation. Besides interfering with AMPs and com-
plement function, SIC also blocks contact activation, prolongs 
blood clotting, and inhibits the release of bradykinin, a potent 
vasodilator (10). The sic gene is regulated by the multiple gene 
regulator of GAS (mga) (11). Mga is a DNA-binding protein that 
activates genes important for invasion. Apart from SIC, mga also 
induces transcription of genes coding for proteins involved in 
adherence, internalization, and immune evasion (11).
Previous in vitro studies have shown that SIC can be con-
sidered as an anti-inflammatory and anti-cytolytic agent (3, 
4, 6–10, 12). In addition, in  vivo experiments in mice have 
demonstrated that a SIC-mutant strain is less virulent than 
a wild-type strain expressing SIC (7). During deep tissue 
infections such as NSTI, neutrophils are recruited to the site 
of infection where they degranulate and release their nuclear 
content also referred to as neutrophil extracellular traps (13). 
Neutrophil extracellular traps consist of DNA and proteins of 
which the majority are histones (14). It was recently reported 
that the released histones contribute to bacterial killing and 
exerts immunomodulatory functions such as the induction of 
cytokine/chemokine production (15–18). Thus, extracellular 
histones act as danger signals, alerting the innate immunity 
of the intruder by interacting with toll-like receptors (TLRs). 
Besides cytokine/chemokine production, histones can cause 
platelet aggregation through forming complexes with fibrino-
gen, thrombin generation, NLRP3 inflammasome activation, 
and trigger lysis of host cells and erythrocytes (17–21). How 
histones exert their antimicrobial activity is not completely 
understood. However, Hirsch (22) described how histones 
adsorbed microbes in a pH-dependent manner. Histones are 
cationic in their amino-terminal portion and neutrally charged 
in their carboxy termini. While the cationicity in histone H1 is 
predominantly constituted by lysine, the cationic charge of his-
tone H2A, H2B, H3, and H4 is mediated by lysines and arginines. 
It is therefore tempting to speculate that histones could interact 
with SIC in a charge-dependent fashion. However, additional 
studies are required to unravel this issue.
Natural infections with S. pyogenes only occur in humans, 
and in the present work we investigate the immunomodulatory 
properties of SIC in human blood. Here, we demonstrate that 
SIC has multiple effects on the host response. First, this paper 
describes the biochemical properties of SIC/histone interactions 
and then continues with its functional effects on the innate 
immune system. We find that besides inhibiting the bacteri-
cidal activity of extracellular histones, SIC forms complexes 
with histones in  vitro and colocalizes in patients with NSTI. 
Furthermore, our data show that SIC/histone complexes induce 
a broad pathological pro-inflammatory cytokine response in 
human blood.
MaTerials anD MeThODs
Patient Material
Tissue biopsies were collected from patients with NSTI enrolled 
at Rigshospitalet, Copenhagen, Denmark, as part of the 
EU-funded project INFECT during 2013–2014 (ClinicalTrials.
gov Identifier: NCT01790698). Also included were biopsies of 
healthy skin tissue obtained at plastic surgery at Karolinska 
University Hospital, Stockholm, Sweden. The studies were 
conducted in accordance with the Helsinki Declaration and 
approved by the regional Ethical Review Board at the Regional 
Ethics committee in Stockholm as well as by the National 
Committee on Health Research Ethics in Copenhagen. Written 
informed consent was obtained from all patients or their legal 
surrogates.
Proteins and antibodies
Histone H1, H2A, H2B, H3.1, and H4 were purchased from 
Bionordika (Stockholm, Sweden) and calf thymus histones 
(histones) from Roche (Basel, Switzerland). [Histone H4-derived 
peptides were synthesized at Biopeptide Co. (San Diego, CA, 
USA).] Peroxidase-conjugated goat anti-rabbit and goat anti-
mice immunoglobulin G were from Bio-Rad Laboratories 
(Berkley, CA, USA). Antibodies against histone H4 (polyclonal 
chip-grade anti-histone H4) were from Abcam (Cambridge, UK). 
Rat polyclonal antibodies to human TLR4, TLR2 and isotype 
control and the TLR4-inhibitor CLI-095 were purchased from 
InvivoGen (San Diego, CA, USA).
Bacterial strains and Protein Purification
The S. pyogenes strain AP1 (M1 serotype) was from World Health 
Organization Collaborating Center for Reference and Research 
on Streptococci, Prague, Czech Republic. SIC was purified from 
S. pyogenes AP1 strain culture medium as described by Åkesson 
et al. (3) by precipitation of the bacterial supernatant (SN) with 
30% ammonium sulfate, followed by ion-exchange chromatog-
raphy on a Mono Q column. SIC fractions were dialyzed against 
20-mM Tris–HCl pH 7.5 and analyzed using SDS-PAGE. The 
SIC-mutant strain was generated as described by Frick et al. (7). 
The SIC preparation used in this study was analyzed by shot-
gun mass spectrometry. No other streptococcal proteins were 
detected and the only contamination found were traces of human 
keratin. Antiserum against SIC and isotype control serum were 
raised in rabbits. SIC was labeled with 125I using Pierce IODO.
BEADS® Iodination reagent (Thermo Scientific, Waltham, MA, 
USA). Molarity calculation of SIC was based on a molecular 
weight of 31,000 Da.
3Westman et al. SIC/Histone Complexes Boost Inflammation
Frontiers in Immunology | www.frontiersin.org February 2018 | Volume 9 | Article 236
Blood collection
Blood was drawn from healthy donors into 6.0-mL sodium 
heparin tubes (Becton Dickinson, Franklin Lakes, NJ, USA) or 
into 2.7-mL 0.109-M sodium citrate tubes (Becton Dickinson, 
Franklin Lakes, NJ, USA). Blood samples were stored at room 
temperature for 30 min before usage.
sic Precipitation, sDs-Page,  
and Western Blotting
Streptococcus pyogenes AP1 bacteria and SIC-mutant bacteria 
were grown for 9 h in Todd–Hewitt (TH) broth at 37°C. After 
6 h, the bacteria were centrifuged at 2,000× g and the SNs were 
sterile filtered. SNs (1  mL) from SIC-producing AP1 and the 
SIC knockout were mixed with 250 µL of 100% trichloroacetic 
acid. Samples were incubated for 10 min at 4°C. All samples were 
centrifuged at 18 000× g for 5 min. The SN was removed from the 
white pellet in bottom of every test tube. Pellets were dissolved 
in 200 µL ice-cold 100% acetone. All samples were centrifuged 
again at 14,000 rpm for 5 min. SN was removed and the pellet was 
dried at 95°C in a heat block for 10 min. Each pellet was dissolved 
in sample buffer (Bio-Rad Laboratories, Berkeley, CA, USA) and 
boiled for 10 min at 95°C. Samples were loaded into a 10% PAGE 
as described by Laemmli (23). Proteins were transferred onto a 
polyvinylidene difluoride membrane (GE Healthcare, Uppsala, 
Sweden), blocked with 5% non-fat milk powder in 10-mM 
PBS, 0.05% Tween-20 (PBS-T), incubated with primary rabbit 
anti-SIC serum (1:1,000), and secondary peroxidase-labeled 
goat anti-mouse IgG (1:3,000, Bio-Rad Laboratories, Berkley, 
CA, USA). All incubation steps were performed at RT for 60 
min on rotation and were followed by three washing steps in 
PBS-T. The polyvinylidene difluoride membrane was developed 
using SuperSignal West Pico Chemiluminescence kit (Thermo 
Scientific, Waltham, MA, USA) according to manufacturer’s 
instructions.
slot Blot
A polyvinylidene difluoride filter (Millipore, Billerica, MA, USA) 
was activated in methanol, washed in destilled water, and exposed 
to different histones subtypes in three different concentrations 
using a Milliblot-D system (Millipore, Billerica, MA, USA). The 
filter was washed with 100-µL PBS, blocked with 5% non-fat milk 
powder in PBS and probed with 125I-labeled SIC (2 × 105 cpm/mL) 
for 3 h in RT. The filter was washed three times for 20 min with 
PBS-T and autoradiography was carried out using Kodak x-Omat 
AR films and regular intensifying screens.
Peptide elisa
Microtiter plates were coated overnight with 100 µL histone 
H4-derived peptides (1 µM) in coating buffer (15.9-mM Na2CO3, 
30-mM NaHCO3, pH 9.6) at 4°C. The next day, plates were 
washed three times in PBS containing 0.05% Tween-20 (PBST) 
and blocked in PBST containing 0.5% bovine serum albumin for 
60 min at 37°C. After blocking and another washing step, plates 
were probed with 100 µL SIC (40 nM) for 1 h at 37°C and binding 
was detected with 100 µL rabbit SIC antisera (1:2,000) followed 
by 100 µL of a peroxidase-conjugated antibody against rabbit IgG 
(1:3,000, Bio-Rad Laboratories, Berkeley, CA, USA). Stabilized 
tetramethylbenzidine Chromogen (Thermo Fischer Scientific, 
Waltham, MA, USA) was used as a substrate for the peroxidase-
conjugated antibody. The reaction was terminated with 10% 
H2SO4 and measured at 450 nm for 0.1 s per measured well.
surface Plasmon resonance
All analyses were performed using a BIAcore X100 instrument 
(GE Healthcare, Uppsala, Sweden). Histone H4 was diluted in 
sodium acetate (10 mM, pH 5.5) and immobilized to a Sensor 
Chip CM5 via amine coupling to flow cell 2. Flow cell 1 was 
immobilized without protein and was used as a control for each 
experiment. SIC (400–25 nM) was injected in a flow (30  µL/
min) over the Sensor Chip in HBS-EP buffer [10-mM HEPES, 
150-mM NaCl, 3-mM EDTA, 0.05% (v/v) Surfactant P20, pH 
7.4]. Regeneration of the Sensor Chip was obtained by injec-
tion of 30 µL 50-mM NaOH. All experiments were run at 25°C 
in degassed buffers. Affinity constants were calculated using 
BIAevaluation software (GE Healthcare, Uppsala, Sweden).
negative staining and Transmission 
electron Microscopy
Binding between SIC and histone H4 was visualized using nega-
tive staining and electron microscopy as previously described 
(24). Histone H4 was conjugated with 10-nm colloidal gold 
particles according to routine protocols (25). Conjugates were 
incubated with each other for 30 min at RT and negatively 
stained with 0.75% uranyl formate. Specimens were examined in 
a Philips/FEI CM100 BioTwin transmission electron microscope 
at a 100,000× magnification.
Bacterial Viable count assay
Streptococcus pyogenes AP1 strain and the SIC-mutant S. pyogenes 
strain were plated overnight at 37°C on blood agar plates and 
stored at 4°C. For each experiment, colonies from the blood agar 
plate were added to 10 mL in TH broth (Sigma-Aldrich, St. Louis, 
MO, USA) and incubated at 37°C overnight. SIC mutant was 
grown in TH broth containing 0.15-mg/mL Kanamycin. The fol-
lowing day, the bacteria were mixed and 200 µL were transferred 
to 10-mL fresh TH broth and incubated to reach logarithmic 
phase (OD620nm 0.4) at 37°C. The bacteria were centrifuged at 
2,000× g and washed in ice cold 10-mM PBS with 5-mM glucose 
(PBS-G). Bacteria were diluted to 2 × 106 colony-forming units 
(CFUs)/mL in PBS-G. Histones (5 µg/mL) or histone H4 (0.36 
µM), with or without increasing concentrations of SIC (0.16, 
0.32, or 0.64 µM), were preincubated for 30 min at 37°C in a 
total volume of 50 µL. The same volume of diluted bacteria was 
added to each sample, and the samples were incubated for 60 
min at 37°C with 5% CO2. All samples were diluted in PBS-G 
and plated on TH agar plates overnight at 37°C. The following 
day, colonies were manually counted and the number of viable 
CFUs was described as a ratio of viable colonies compared with 
non-stimulated bacteria.
hemolysis assay
Citrated blood (1 mL) was centrifuged at 2,000× g for 10 min 
to pellet cells. The blood plasma was discarded and replaced by 
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an equal volume of PBS. This washing procedure was repeated 
twice. Histones and SIC were preincubated for 30 min at 37°C and 
erythrocytes were then added to each sample in a final dilution of 
5% (v/v). After 60 min incubation at 37°C on rotation, all samples 
were centrifuged at 5,000× g for 10 min. The SN was transferred 
to a 96-well plate (Thermo Scientific, Waltham, MA, USA) and 
hemolysis was measured at 540 nm. Histone-induced hemolysis 
was presented as percentage of lysis buffer (0.1% Triton X-100)-
induced hemolysis.
cytokine Production in Blood
Histones (50 µg/mL), LL-37 (25 µg/mL), β defensin-3 
(25 µg/mL), high-mobility group box 1 (HMGB1, 25 µg/mL), 
heparin-binding protein (HBP, 25 µg/mL), SIC (0.64 µM), or 
the AMPs in combination with different SIC concentrations 
were incubated with heparinized blood diluted 1:1 in PBS for 
7 h at 37°C on rotation. For inhibition experiments, antibodies 
against human TLR4 (25 µg/mL), human TLR2 (25 µg/mL), 
isotype control (25 µg/mL), or the TLR4 inhibitor CLI-095 
(1–10 µg/mL) were added simultaneously to histones and 
SIC. Blood aliquots were removed at different time points 
and centrifuged at 2,000× g for 10 min. The plasma SN was 
removed and frozen at −20°C. IL-6 was measured in heparin 
plasma SN using Human IL-6 Quantikine ELISA kit (R&D 
Systems, Minneapolis, MN, USA) using the manufacturer’s 
instructions. Samples were discarded after the IL-6 measure-
ments and were not repeatedly frozen.
immunostaining of Tissue Biopsies
Snap-frozen tissue biopsies from healthy controls or from patients 
with NSTI caused by M1 or M3 S. pyogenes strains were analyzed. 
The biopsies were cryosectioned to 8 µm and fixed in ice-cold 
acetone or 2% formaldehyde for immunofluorescent or immuno-
histochemical stainings, respectively. Stainings were performed 
in singlets on consecutive sections as described previously 
(16, 17, 26, 27). The following antibodies were used at predeter-
mined optimal concentrations: mouse monoclonal anti-histone 
H4 (Abcam, Cambridge, UK), rabbit anti-SIC serum, goat poly-
clonal anti-Lancefield group A carbohydrate (Abcam, Cambridge, 
UK), and rabbit polyclonal antibodies against human HMGB1 
(Abcam, Cambridge, UK) and human IL-8/NAP-1 (Invitrogen, 
Waltham, MA, USA). Biotinylated secondary antibodies included 
rabbit-anti-goat IgG and goat-anti-rabbit IgG (both from Vector 
Laboratories, Burlingame, CA, USA). For fluorescence stainings, 
Alexa 546 conjugated donkey anti-rabbit IgG and Alexa 488 con-
jugated donkey anti-mouse IgG (both from Molecular Probes, 
Eugene, OR, USA) were used. Slides were mounted using DAPI-
supplemented mounting media (Molecular Probes, Eugene, OR, 
USA). Single stainings were performed to assure specificity of 
staining patterns. For image evaluation, a Nikon A1R confocal 
microscope was used (Nikon Instruments, Amstelveen, the 
Netherlands). The immunohistochemically stained sections 
were analyzed by acquired computerized image analysis (ACIA) 
as previously described (28). The cell area was defined by the 
hematoxylin counterstaining and the results are presented as 
ACIA values, which equal the percentage of positively stained 
area × mean intensity of positive staining.
Multiplex cytokine Quantification assay
The cytokine analysis was performed using a Bio-Plex 200 
instrument and a Bio-Plex Pro Human Cytokine 27-Plex Assay 
(both from Bio-Rad Laboratories, Berkeley, CA, USA) FGF basic, 
Eotaxin, G-CSF, GM-CSF, IFN-γ, IL-1β, IL-1ra, IL-2, IL-4, IL-5, 
IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, CXCL10, 
CCL2, CCL3, CCL4, PDGF-bb, RANTES, TNF-α, and VEGF. The 
cytokine panel was designed to provide a measure of cytokines, 
chemokines, and growth factors. All samples, standards, and con-
trols were run in duplicates and data was acquired using Bio-Plex 
Manager Software (version 6.1).
statistical analyses
Data were analyzed using GraphPad Prism 7 (GraphPad Soft-
ware, San Diego, CA, USA). One-way ANOVA with Dunnett’s or 
Tukey’s test was used to determine significance between multiple 
comparisons.
resUlTs
expression of sic and Binding of sic to 
extracellular histones
Before investigating the interaction between SIC and his tones, the 
production of the streptococcal protein in the strains employed 
in this study was determined. The S. pyogenes iso lates AP1 (wild-
type) and the isogenic S. pyogenes-mutant strain-lacking SIC 
(SIC-mutant) were used throughout this study. The SNs from 
both bacterial strains were collected at 6  h, precipitated with 
trichloroacetic acid, and SIC was visualized using SDS-PAGE 
(Figure  1A; Figure S1A in Supplemen tary Material) followed 
by Western blot analysis using anti sera against SIC (Figure 1B; 
Figure S1B in Supplementary Material). The results show that 
SIC is secreted from the wild-type, but not expressed in the SIC-
mutant strain, and they also reveal that SIC is the most abundant 
protein secreted from S. pyogenes under these culture conditions 
(Figure 1A). No SIC expression was detected when the mutant 
strain was analyzed (Figures 1A,B).
Previous work has shown that SIC is highly anionic and 
interacts with a number of different AMPs (5–7). As extracellular 
histones are, like AMPs, positively charged, we sought to study a 
possible interaction between SIC and histones. The five different 
histone subtypes were immobilized in different concentrations 
on an Immobilon filter and probed with 125I-labeled SIC. The 
slot blot depicted that SIC interacts with histones H3 and H4 but 
not with histones H1, H2A, or H2B (Figure 1C). Histone H4 is 
highly cationic (net charge + 19) and it was recently described to 
trigger a number of pathological reactions such as the aggrega-
tion of platelets, hemolysis of erythrocytes, and the production 
of chemokines under in vitro and in vivo conditions (15–19, 29). 
Based on these results, we decided to focus on histone H4 in subse-
quent experiments. To this end, we first confirmed the interaction 
between SIC and histone H4 using Surface Plasmon Resonance 
technology. These experiments revealed that SIC and histone H4 
associate rapidly followed by a slow dissociation phase, resulting 
in an affinity constant which was in the lower nanomolar range 
(Table 1 and Figure 1D). To map the SIC/histone H4 interaction 
FigUre 1 | Streptococcal inhibitor of complement (SIC) expression and its binding to histones. (a) S. pyogenes wild-type and SIC-mutant SNs were precipitated 
with trichloroacetic acid and separated on a 10% SDS-PAGE. (B) SIC was identified in SNs using rabbit antisera against SIC. (c) An Immobilon filter was 
immobilized with different histone subtypes, incubated with 125I-labeled SIC and bound probe was detected with the Fuji FLA-3000 imaging system. (D) SPR 
technology was used to show the interaction between histone H4 and SIC. Histone H4 was coated on a CM5 Sensor Chip and SIC was applied in a flow at different 
concentrations. (e) Microtiter plates were coated with histone H4-derived peptides and probed with SIC. Binding was detected using rabbit antisera against SIC 
and visualized by a peroxidase-conjugated secondary antibody. Data show means ± SEM (one-way ANOVA, Tukey’s test). All experiments were independently 
performed at least three times and one representative image is shown. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
TaBle 1 | Affinity constants for the binding of SIC to histone H4.
sample ka(1/Ms) kd(1/s) KD(M)
Protein SIC 3.347 × 104 5.908 × 10−4 1.765 × 10−8
Histone H4 was immobilized to a Biacore CM5 Sensor Chip and different 
concentrations of SIC were applied in a flow. Affinity constants for SIC/histone H4 
binding were determined using BIAevaluation software (GE Healthcare, Uppsala, 
Sweden).
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site, overlapping histone H4-derived peptides were coated on 
a 96-well plate, incubated with SIC and immunodetected with 
antisera against SIC. The cationic charge distribution of histone 
H4 is localized to its N-terminus. This site, covered by peptide 
MSG20 (amino acids 1–20), is the only peptide that had affinity 
for SIC (Figure 1E). The binding between SIC and histone H4 
was also analyzed by negative staining electron microscopy. SIC 
has three structural domains; a short repeat region, a long repeat 
region, and a proline-rich region (3, 12). These three domains 
form a linear structured protein (Figure  2A) that provides 
two distinct binding sites for histone H4. In complex with SIC, 
histone H4 appears as a globular folded protein (Figure  2B). 
Notably, binding of histone H4 did not change the conformation 
of SIC. In the next series of experiments, histone H4 was labeled 
with colloidal gold and its interaction with SIC was visualized 
(Figure 2C). While monomeric negatively stained SIC is depicted 
in Figures 2A–C, the vast majority of SIC and histone H4 were 
found in clusters suggesting that they may form larger aggregates 
(Figure S2A in Supplementary Material) or oligomers (Figure 
S2B in Supplementary Material). Taken together, the results 
underline that SIC is a highly abundant secreted protein in the 
S. pyogenes M1 strains, and that the protein specifically interacts 
with histones H3 and H4, but not with histones H1, H2A, and 
H2B, respectively. Moreover, we found that SIC binds to the 
N-terminal part of histone H4, which is the most cationic part 
of the protein, and can form complexes with up to two histone 
molecules simultaneously.
sic interfering with antimicrobial and 
hemolytic activity of extracellular 
histones
Extracellular histones and other AMPs are potent kill-
ers of a broad range of bacterial pathogens (22, 30, 31). To 
FigUre 2 | Negative staining electron microscopy of SIC in complex with histone H4. Right panel shows a duplicate of the left panel, but with SIC (green) and 
histone H4 (red) illustrated in pseudocolors. (a) Linear SIC monomers in the absence of a ligand. (B) Histone H4 was added to SIC and prepared for negative 
staining electron microscopy. SIC monomers are depicted with one or two bound molecules of histone H4. (c) Histone H4 was labeled with 10-nm colloidal gold 
and added to SIC. SIC monomers binds to one or two molecules of histone H4 conjugated to gold particles. Scale bar 25 nm.
6
Westman et al. SIC/Histone Complexes Boost Inflammation
Frontiers in Immunology | www.frontiersin.org February 2018 | Volume 9 | Article 236
counteract a cytotoxic attack by such substances, S. pyogenes 
has developed several strategies to cope with these host 
responses, including the secretion of SIC. It was previously 
reported that SIC inhibits the bactericidal activity of LL-37 
(7) and several defensins (5, 7) and it also interferes with 
the contact and complement systems (6, 10). In the case of 
AMPs, it has been reported that SIC prevents their interaction 
with the bacterial membrane (3–10). Based on these find-
ings, we sought to determine whether SIC interferes with the 
bactericidal activity of histones. To investigate the effect of 
SIC on histones, we performed viable count assays. Wild-type 
bacteria were grown to log-phase, extensively washed, and 
diluted to enable determination of viability by measuring 
CFUs. As the washing steps let to a depletion of endogenously 
produced SIC, resuspended bacteria were reconstituted with 
SIC purified from the wild-type SN. Reconstituted and non-
reconstituted wild-type S. pyogenes bacteria were incubated 
with histones or histone H4. After 60-min incubation, bac-
teria were plated and enumerated the next day to determine 
the viability. Addition of SIC rescued bacteria in a dose-
dependent manner against histones (Figure 3A) and histone 
H4 (Figure  3B) and similar results were obtained when the 
SIC mutant was analyzed (Figure  3C). Besides perforating 
bacterial membranes, extracellular histones can lyse eukary-
otic cells including erythrocytes and thereby cause hemolysis, 
a common characteristic of systemic inflammatory response 
syndromes (17). To investigate if SIC can block histone-induced 
hemolysis, erythrocytes were washed and diluted in PBS. 
Histones were then added to induce hemolysis. In the absence 
of SIC, histone-induced hemolysis occurred after 60 min while 
increasing concentrations of SIC rescued erythrocytes from 
histone-induced hemolysis (Figure 3D). These results suggest 
that SIC neutralizes the lytic activity of extracellular histones 
toward both bacterial and human cell membranes.
sic/histone complexes Triggering the 
induction of Multiple cytokines and 
chemokines
Extracellular histones were recently described to act as danger-
associated molecular patterns (or danger signals) as they can 
induce cytokine (15) and chemokine production (16) and trigger 
leukocyte migration in vivo (16). Cytokines such as TNF-α, IL-6, 
IL-8, CXCL10, and IFN-γ are released upon histone stimulation, 
and it has been reported that their release is dependent on differ-
ent TLRs (15, 16, 20, 21). As our data demonstrated that SIC can 
block the cytolytic activity of histones, we wished to investigate 
whether it also inhibits histone-induced release of these inflam-
matory mediators. Using Bioplex multiplex assays, blood from 
healthy donors were incubated with histones in the absence 
or presence of SIC and a panel of 27 cytokines, chemokines, 
and growth factors were measured. Under these experimental 
conditions, histones alone acted often as weak or moderate 
inducers of cytokines/chemokines (Figure 4). However, histones 
in complex with SIC boosted the pro-inflammatory response, 
yielding a robust increase of cytokines/chemokines such as 
TNF-α (Figure  4A), IL-8 (Figure  4B), IL-1β (Figure  4C), 
IL-1ra (Figure  4D), G-CSF (Figure  4E), IFN-γ (Figure  4F), 
and IL-6 (Figures 5A,B). SIC alone had no effect on the induc-
tion of these proteins except for one donor. Interestingly, the 
coincubation with SIC did not always boost the inflammatory 
response. For example, histone-induced PDGF-bb expression 
was to some extent blocked by SIC (Figure  4G) and SIC did 
not affect histone-induced CXCL10 production (Figure  4H). 
Furthermore, a broad range of cytokines were not affected by 
either histones or SIC, or not significantly elevated (Figure S3 
in Supplementary Material). This shows that SIC together with 
histones induced a potential pathological response of a broad 
range of cytokines and chemokines.
FigUre 3 | SIC inhibiting the cytolytic activity of histones. S. pyogenes wild-type were grown to mid-log phase, washed, and diluted to 2 × 106 CFU/mL. Histones 
(a) and SIC or histone H4 (B) and SIC were preincubated for 1 h, and mixed with the wild-type bacteria for 1 h at 37°C. (c) S. pyogenes SIC mutant was prepared 
as described above. Histones and SIC were preincubated for 1 h, and mixed with the SIC mutant for 1 h at 37°C. Samples were diluted and plated on TH agar 
plates and CFU were determined the following day. Data show mean ± SEM (one-way ANOVA Dunnett’s test). (D) Erythrocytes were diluted to 5% (v/v) in PBS and 
incubated with histones and different concentrations of SIC for 1 h. Hemolysis was measured at 540 nm in supernatants after centrifugation, and was expressed as 
percentage of erythrocytes treated with 0.1% Triton X-100. Data show mean ± SEM (one-way ANOVA Dunnet’s test). All experiments were independently performed 
at least three times. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
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sic increasing histone-induced il-6 
Production via Tlr4
To investigate the target receptor of SIC/histone-induced cytokine 
production, we focused on IL-6. First we confirmed, using blood 
from one donor, that SIC/histone-complexes can induce IL-6 
production (Figure 5A). Interestingly, the IL-6 production was 
amplified when the SIC concentration was increased (Figure 5A). 
Then we repeated the experiment using several donors at the most 
potent SIC concentration (Figure 5B). Our previous studies have 
shown that histones induce chemokine production by binding to 
the TLR4/MD-2 complex (16). To investigate whether this path-
way is responsible for the enhancing effect, SIC and histones were 
added to human blood together with the TLR4-inhibitor CLI-
095 or inhibitory antibodies against TLR4, TLR2, or an isotype 
control. Figures  5C,D depict that blocking the TLR4 response 
almost completely abrogated IL-6 production, suggesting that the 
interaction of SIC with extracellular histones can contribute to 
FigUre 4 | Continued
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the release of pathological levels of IL-6 involving an activation 
of the TLR4 signaling pathway.
To investigate whether the SIC-induced amplification of 
inflammation applies not only to histones, but also to other 
cationic SIC-binding AMPs, we incubated blood from healthy 
donors together with LL-37, β defensin-3, HMGB1, and HBP 
in the absence or presence of SIC. Subsequent Bioplex multiplex 
assays revealed that SIC boosted cytokine/chemokine production 
of LL-37, β defensin-3, and HMGB1, but had no effect on HBP 
(Figure S4 in Supplementary Material). These findings indicate 
that the pro-inflammatory property of SIC applies to several 
cationic AMPs, including histones, with important functions in 
the innate immune system.
sic and extracellular histones Present  
at the infected Tissue site in Patients  
with necrotizing soft-Tissue infection
S. pyogenes strains of the M1 serotype are among the most fre-
quently identified serotypes isolated from patients with severe 
invasive infections including NSTI and toxic shock syndrome 
FigUre 4 | SIC/histone complexes inducing the release of a broad range of cytokines and chemokines. Heparinized blood diluted 1:1 in PBS was stimulated with 
either histones (n = 6), histones with SIC (n = 6), SIC alone (n = 4), or PBS (n = 6) for 7 h at 37°C. Plasma SNs were analyzed for a panel of cytokines, chemokines, 
and growth factors including TNF-α (a), IL-8 (B), IL-1β (c), IL-1ra (D), G-CSF (e), IFN-γ (F), PDGF-bb (g), and CXCL10 (h) using a Bio-Plex cytokine quantification 
assay. Data show mean ± SEM (one-way ANOVA, Tukey’s test). All samples were measured in duplicates. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
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(32). We previously reported that in patients with NSTI, histones 
from necrotic cells are released into the extracellular compart-
ments (16, 17). As invasive S. pyogenes strains often belong to 
the M1 serotype and secrete large quantities of SIC under in vitro 
conditions (7), we investigated whether SIC is released in NSTI 
patients, and if so, whether it is found to colocalize with histones. 
To this end, tissue sections from biopsies of patients infected 
with S. pyogenes M1 or M3 (a serotype negative for SIC) strains 
were analyzed with immunofluorescence staining. As shown in 
Table 2, we analyzed three biopsies that were positively stained for 
HMGB1, a marker for disease severity (33). All analyzed sections 
exhibited signs of inflammation (IL-8) and were colonized with 
FigUre 5 | SIC/histone complexes inducing IL-6 production via TLR4. (a) Heparinized blood was diluted 1:1 in PBS. Histones (50 µg/mL) and different 
concentrations of SIC were preincubated for 1 h and added to the blood. Samples were incubated for 7 h at 37°C and IL-6 was measured in the plasma SN.  
Data show mean ± SEM (n = 3). (B) Heparinized blood from six donors was investigated for IL-6 production after incubation with SIC/histone complexes for 7 h at 
37°C. Data show mean ± SEM (one-way ANOVA, Tukey’s test). IL-6 production was measured in blood incubated with histones, SIC, and different concentrations 
of the TLR4 inhibitor CLI-095 (n = 3) (c) or anti-TLR4 antibodies (25 µg/mL) (n = 3), anti-TLR2 antibodies (25 µg/mL) (n = 3), or isotype control (25 µg/mL) (n = 3) 
(D). Values are expressed as fold increase to diluted blood stimulated with PBS. Data show mean ± SEM (one-way ANOVA, Tukey’s test). *P ≤ 0.05, **P ≤ 0.01, 
and ***P ≤ 0.001.
TaBle 2 | Analysis of biopsies from patients with S. pyogenes necrotizing soft-
tissue infections.
Patient iD M type hMgB1 il-8 gas
2001 M1 30 51 24
2006 M1 47 81 65
2028 M3 57 65 51
Healthy control Negative Negative Negative Negative
Biopsies were stained with antibodies against high-mobility group (HMGB1), IL-8, and 
the Lancefield group-specific carbohydrate identifying group A Streptococcus (GAS), 
and the stainings were quantified using acquired computerized image analysis.
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S. pyogenes (GAS). Moreover, a biopsy from a healthy donor was 
included with undetectable levels of HMGB1, IL-8, and S. pyo-
genes. The four biopsies were stained with antibodies against SIC 
(red) and histone H4 (green) as well as with the nuclear DNA stain 
DAPI (blue). Histone H4 was readily detected in tissue sections 
from both M1- and M3-infected patients, as well as in the biopsy 
from a healthy control (Figure S5 in Supplementary Material). 
SIC showed a strong staining in the M1-infected tissue (Figures 
5A,B in Supplementary Material), whereas in the M3 only a back-
ground staining was noted (Figure 5C in Supplementary Material). 
FigUre 6 | Continued
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Moreover, we recorded a few areas of colocalization between 
SIC and histone H4 in the biopsy sections from M1 patients 
(Figures 6A,B), indicative of a potential SIC/histone H4 complex 
formation at the infected tissue site. Histone H4 but not SIC was 
detected in the biopsy from a healthy donor (Figure 6C; Figure 
5D in Supplementary Material). Taken together, these findings 
demonstrate that SIC is expressed and released during S. pyogenes 
NSTI and that SIC is present in areas with extracellular histones 
and may form complexes at the infected tissue site of patients with 
NSTI. To conclude, our data show that SIC can form complexes 
with histones in vitro, and block histone-mediated effects on both 
bacterial and eukaryotic membranes. Furthermore, we found that 
SIC/histone complex formation synergistically increases a broad 
and potentially pathological inflammatory response in human 
blood. Lastly, we demonstrate that SIC is expressed in patients 
suffering from NSTI and that SIC partly colocalize with histones, 
suggesting that complex formation also occurs in patients with 
invasive streptococcal skin infections.
DiscUssiOn
In the present study, we found that SIC can boost pro- 
inflammatory responses in human blood by forming complexes 
with histones. The streptococcal protein was initially recognized 
for its ability to inhibit the complement system by binding 
to the C5b–C9 complex, also known as the membrane attack 
complex, hence the name streptococcal inhibitor of complement 
(3). Although this interaction has been intensively studied, the 
pathophysiological role is not completely understood. Notably, 
S. pyogenes is resistant to complement-mediated lysis because of 
its thick peptidoglycan layer (4). These findings suggest that SIC 
may employ additional functions beyond blocking the comple-
ment system. For example, the extensive list of AMPs including 
extracellular histones constitutes another important group of SIC 
ligands. AMPs, such as LL-37 and defensins, are expressed by 
epithelial cells in the upper respiratory tract (34, 35). Despite this 
antimicrobial environment, S. pyogenes colonizes the pharynx of 
up to 30% of the population without being killed.
Within the last years, there have been a couple of studies show-
ing that the interaction between SIC and host-derived proteins 
helps the bacteria to escape elimination by host defense systems. 
For instance, streptoccocal survival in saliva is decreased when 
SIC-mutant strains are employed (36) and similar findings were 
published using a murine model of oropharyngeal infection (37). 
Based on these and other reports, we hypothesize that under these 
or other non-inflammatory conditions, SIC is needed to protect 
streptococci from an otherwise lethal immune attack. Thus, it 
seems that SIC helps to establish a non-inflammatory environ-
ment when the bacteria need to colonize and start to proliferate. 
However, under invasive conditions, SIC can contribute to the 
induction of systemic inflammatory reactions. For instance, SIC 
is upregulated when exposed to blood. Maximum levels of sic 
expression is detected already 30 min after its exposure to blood 
(38). It should be noted that SIC levels are increased together 
with other mga-regulated mediators such as fibronectin-binding 
proteins, collagen-like surface proteins, C5a peptidase, and 
M-proteins. Like SIC, these proteins can evoke pro-inflammatory 
FigUre 6 | Streptococcal inhibitor of complement (SIC) expression and 
colocalization with histone H4 in patients with necrotizing soft-tissue 
infection. Snap-frozen biopsies from patients with infections caused by M1 
(a,B) S. pyogenes strains were analyzed for SIC (red) and histone H4 (green) 
expression. DNA is stained with DAPI (blue). A biopsy from a healthy donor 
was used as a control (c). To confirm colocalization of the two markers, 
vertical planes of the indicated areas are shown, demonstrating colocalization 
in (a,B). Scale bar 20 µm.
TaBle 3 | Alignment of the N-terminal of all histone subclasses.
Protein n-terminal sequence net 
charge
arginines 
(r)
lysines 
(K)
Histone H1 MTENSTSAPAAKPKRAKASK  + 4 1 4
Histone H2A MSGRGKQGGKARAKAKTRSS  + 7 3 4
Histone H2B MPEPAKSAPAPKKGSKKAVT  + 4 0 5
Histone H3.1 MARTKQTARKSTGGKAPRKQ  + 7 3 4
Histone H4 MSGRGKGGKGLGKGGAKRHR  + 7 3 4
The first 20 amino acids of each histone are depicted below, together with their net 
charge, and their arginine- and lysine content.
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reaction which in concert can lead to life-threatening complica-
tions as, for instance, seen in patients suffering from streptococ-
cal necrotizing fasciitis. During these necrotic conditions, SIC 
can form complexes with extracellular histones that in turn 
induce cytokine production, thereby causing an overwhelming 
and pathological inflammatory response. Using other danger 
signals such as LL-37, β defensin-3, and HMGB1, we find similar 
boosting activities of SIC (Figure 4 in Supplementary Material), 
suggesting that the protein is a general enhancer of inflammatory 
reactions once the immune system is alerted.
When testing different histone subclasses, we found that SIC 
binds exclusively to histone H3 and H4, which shows a specific-
ity between the cationic histone subclasses. Our previous results 
with TLR antagonists demonstrated that extracellular histones 
alone can induce cytokine production through TLR4 on mono-
cytes and macrophages (16). Noteworthy, SIC/histone complexes 
also induce IL-6 production through TLR4, suggesting that it 
activates the receptor using the same molecular mechanisms. 
In the same study, the cytokine-inducing residues of histone 
H4 was mapped to amino acids 35–54 (IRR20) (16). This bind-
ing site is different from the SIC-binding region that we have 
mapped to amino acids 1–20 (MSG20) of the N-terminal region 
of histone H4. These findings suggest a plausible explanation 
for how histone H4 can interact with SIC and simultaneously 
activate TLR4.
Since the cationic N-terminal part of histone H4 is 
responsible for the binding to SIC, the N-terminal parts of all 
histone subclasses were compared. The segments spanning the 
first 20 amino acids of histones H4 and H4 have both a net 
charge of +7, mediated by three arginine residues and four 
lysine residues. The corresponding sequences in H1 and H2B 
have one or no lysine residue, respectively, and a net charge 
of +4 (Table 3). Arginine is known to be cytotoxic to plasma 
membranes, and this may be an evolutionary reason as to why 
SIC has acquired affinity for H3 and H4 specifically. Though 
histone H2A has the same distribution of arginine and lysine 
residues and also a net charge of +7, it fails to interact with 
SIC. This finding may also indicate that structural elements are 
important for the interaction of SIC with histones. However, 
more experimental support is needed to draw a conclusive 
explanation for our results.
In order to cause inflammation SIC has to interact with host 
proteins. This is in contrast to bacterial virulence factors which 
exert their pathological activity by interacting directly with 
their target receptor or cell. However, there are apart from SIC 
also other important virulence determinants using a similar 
approach. For example, LPS is using LPS-binding protein, a 
soluble acute-phase protein, to elicit immune responses through 
TLR4 (39). Streptococcal M-protein activates neutrophils by 
forming complexes with fibrinogen, while M-protein-induced 
TLR2 activation does not require fibrinogen (40). S. pyogenes and 
Staphyloccocus aureus release streptokinase and staphylokinase, 
respectively, two enzymes that can activate plasminogen and help 
the bacteria to disseminate from the site of infection (41) strep-
tokinase (42). These examples show the sophisticated adaption of 
different pathogens to modulate the immune response and cause 
pathologic conditions.
To summarize, our in  vitro data reveal that SIC/histone 
complexes elicit a broad upregulation of multiple pro-inflam-
matory cytokines, and it seems reasonable to speculate that 
SIC/histone complexes are formed in vivo as well. This leads to 
a cascade of events that amplifies inflammation and worsens 
the outcome of the infection, although the complex formation 
in  vivo has to be further studied. Our study therefore shows 
that SIC has a Janus-faced function as it, on one hand, dampens 
the host reaction to infection, but on the other hand by its 
interaction with danger signals trigger massive inflammatory 
reactions.
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